TY - JOUR
T1 - Parenteral nutrition and insulin per protocol improve diabetes management after total pancreatectomy
AU - Andersen, Sakshi
AU - Andersen, Andreas
AU - Ringholm, Lene
AU - Hansen, Carsten Palnæs
AU - Storkholm, Jan
AU - Lillpers, Kerstin
AU - Schiøtz, Charlotte
AU - Mathiesen, Elisabeth Reinhardt
N1 - Articles published in the DMJ are “open access”. This means that the articles are distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
PY - 2018/4
Y1 - 2018/4
N2 - INTRODUCTION: Pancreatogenic diabetes develops in patients undergoing total pancreatectomy and complicates post-surgical management. The aim of this study was to compare parenteral nutrition (PN) with protocolled insulin treatment to intravenous glucose treatment after total pancreatectomy.METHODS: This was a retrospective study of 97 patients undergoing total pancreatectomy between 2009 and 2014. Patients were divided into a PN cohort (n = 57) and a glucose cohort (n = 40). The PN cohort was given PN with one international unit (IU) rapid-acting insulin per 10 g of carbohydrate. The glucose cohort was given a continuous 5% glucose infusion with 2 IU rapid-acting insulin per 10 g of carbohydrate. Both cohorts were given insulin detemir 0.2 IU/kg/day.RESULTS: Within the first 13 post-operative days, plasma glucose values were within the target range (4.0-10.0 mmol/l) in the PN cohort more frequently than in the glucose cohort (46% versus 42%, p = 0.01) without any increase in hypoglycaemia. Non-infectious complications occurred less frequently in the parenteral cohort than in the glucose cohort (23% versus 43%, p = 0.04). Infectious complications occurred in 19% versus 33% of patients, respectively (p = 0.14). The mean length of hospitalisation was 19.8 ± 12.7 versus 25.0 ± 21.5 days, p = 0.14.CONCLUSIONS: After total pancreatectomy, PN with insulin treatment per protocol improves glycaemic control compared with glucose infusion and reduces the number of non-infectious post-operative complications without increasing hypoglycaemia.FUNDING: none.TRIAL REGISTRATION: not relevant.
AB - INTRODUCTION: Pancreatogenic diabetes develops in patients undergoing total pancreatectomy and complicates post-surgical management. The aim of this study was to compare parenteral nutrition (PN) with protocolled insulin treatment to intravenous glucose treatment after total pancreatectomy.METHODS: This was a retrospective study of 97 patients undergoing total pancreatectomy between 2009 and 2014. Patients were divided into a PN cohort (n = 57) and a glucose cohort (n = 40). The PN cohort was given PN with one international unit (IU) rapid-acting insulin per 10 g of carbohydrate. The glucose cohort was given a continuous 5% glucose infusion with 2 IU rapid-acting insulin per 10 g of carbohydrate. Both cohorts were given insulin detemir 0.2 IU/kg/day.RESULTS: Within the first 13 post-operative days, plasma glucose values were within the target range (4.0-10.0 mmol/l) in the PN cohort more frequently than in the glucose cohort (46% versus 42%, p = 0.01) without any increase in hypoglycaemia. Non-infectious complications occurred less frequently in the parenteral cohort than in the glucose cohort (23% versus 43%, p = 0.04). Infectious complications occurred in 19% versus 33% of patients, respectively (p = 0.14). The mean length of hospitalisation was 19.8 ± 12.7 versus 25.0 ± 21.5 days, p = 0.14.CONCLUSIONS: After total pancreatectomy, PN with insulin treatment per protocol improves glycaemic control compared with glucose infusion and reduces the number of non-infectious post-operative complications without increasing hypoglycaemia.FUNDING: none.TRIAL REGISTRATION: not relevant.
KW - Adenocarcinoma
KW - Aged
KW - Blood Glucose/metabolism
KW - Chi-Square Distribution
KW - Diabetes Mellitus/drug therapy
KW - Female
KW - Humans
KW - Hypoglycemic Agents/administration & dosage
KW - Infusions, Intravenous
KW - Insulin/administration & dosage
KW - Insulin Aspart
KW - Length of Stay/statistics & numerical data
KW - Male
KW - Middle Aged
KW - Pancreatectomy/adverse effects
KW - Pancreatic Neoplasms/surgery
KW - Parenteral Nutrition/methods
KW - Postoperative Complications/drug therapy
KW - Retrospective Studies
KW - Statistics, Nonparametric
M3 - Journal article
C2 - 29619926
SN - 2245-1919
VL - 65
JO - Danish Medical Journal
JF - Danish Medical Journal
IS - 4
ER -